Suzuki K, Hatzikotoulas K, Southam L, Taylor HJ, Yin X, Lorenz KM, Mandla R, et al
We spent months reviewing and comparing the top GLP-1 programs available in 2026, evaluating each one on medical oversight, pharmacy quality, pricing transparency, and helpful patient support
At the same time, supportive regulatory approvals and growing healthcare coverage are facilitating wider market penetration while pharmaceutical innovations like oral formulations and longer-acting injectables are improving patient convenience and compliance
The right choice ultimately depends on your goals, individual response and how well you tolerate side effects, something best discussed with your provider to find the most suitable option
Activating GLP-1R inhibited TGF-1 + IL-1-induced fibroblast activation by disrupting the interaction between the NLRP3 inflammasome and PFKFB3-driven glycolysis and subsequently prevented lactate-mediated histone lactylation to reduce pro-fibrotic gene expression